Senate Bill 3250
116th Congress(2019-2020)
DHS Opioid Detection Resilience Act of 2020
Introduced
Introduced in Senate on Feb 4, 2020
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
3250
Congress
116
Policy Area
Crime and Law Enforcement
Crime and Law Enforcement
Primary focus of measure is criminal offenses, investigation and prosecution, procedure and sentencing; corrections and imprisonment; juvenile crime; law enforcement administration. Measures concerning terrorism may fall under Emergency Management or International Affairs policy areas.
No Senate votes have been held for this bill.
Summary
DHS Opioid Detection Resilience Act of 2020
This bill establishes new requirements related to the detection of illicit narcotics at ports of entry.
Specifically, U.S. Customs and Border Protection (CBP) must implement a strategy to ensure chemical screening devices are able to identify narcotics at purity levels equal to or less than 10%, or provide an alternate method for identifying narcotics at lower purity levels. The CBP must also test new chemical screening devices at various purity levels before it commits to their acquisition.
Additionally, the Department of Homeland Security must implement a plan for the long-term development of a centralized spectral database for chemical screening devices.
February 4, 2020
02/04/2020
Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
02/04/2020
Introduced in Senate
Public Record
Record Updated
Feb 8, 2022 11:22:55 PM